P63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis

Cell Death and Differentiation

Volumn 21, Issue 4, 2014, Pages 645-654

  Yallowitz, A R ^a   Alexandrova, E M ^a   Talos, F ^a   Xu, S ^a   Marchenko, N D ^a   Moll, U M ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

ErbB2 breast cancer; involution; mammary gland; p63; PI MECs; stem cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ONCOSTATIN M; PROTEIN P21; PROTEIN P53; PROTEIN P63; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL COUNT; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOARCHITECTURE; HISTOPATHOLOGY; IN VIVO STUDY; INVOLUTION; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; OVERALL SURVIVAL; PARITY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TRANSGENICS; UPREGULATION;

MUS;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE-FREE SURVIVAL; EPITHELIAL CELLS; FEMALE; HETEROZYGOTE; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOPROTEINS; PREGNANCY; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 84903372167     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.199     Document Type: Article

References (68)

1. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-718.
2. Crum CP, McKeon FD. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol 2010; 5: 349-371.
3. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001; 98: 3156-3161.
4. Senoo M, Pinto F, Crum CP, McKeon F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007; 129: 523-536.
5. Hennighausen L, Robinson GW. Information networks in the mammary gland. Nat Rev Mol Cell Biol 2005; 6: 715-725.
6. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM. An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 2000; 5: 227-241.
7. Watson CJ, Kreuzaler PA. Remodeling mechanisms of the mammary gland during involution. Int J Dev Biol 2011; 55: 757-762.
8. Baxter FO, Neoh K, Tevendale MC. The beginning of the end: death signaling in early involution. J Mammary Gland Biol Neoplasia 2007; 12: 3-13.
9. Duijf PH, Vanmolkot KR, Propping P, Friedl W, Krieger E, McKeon F et al. Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63. Hum Mol Genet 2002; 11: 799-804.
10. Vanbokhoven H, Melino G, Candi E, Declercq W. p63, a story of mice and men. J Invest Dermatol 2011; 131: 1196-1207.
11. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominantnegative activities. Mol Cell 1998; 2: 305-316.
12. Candi E, Dinsdale D, Rufini A, Salomoni P, Knight RA, Mueller M et al. TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 2007; 6: 274-285.
13. Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, Zhanxiang W et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002; 198: 417-427.
14. Romano RA, Smalley K, Magraw C, Serna VA, Kurita T, Raghavan S et al. DeltaNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation. Development 2012; 139: 772-782.
15. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006; 20: 3185-3197.
16. Wolff S, Talos F, Palacios G, Beyer U, Dobbelstein M, Moll UM. The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins. Cell Death Differ 2009; 16: 1108-1117.
17. Su X, Paris M, Gi YJ, Tsai KY, Cho MS, Lin YL et al. TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 2009; 5: 64-75.
18. DiRenzo J, Signoretti S, Nakamura N, Rivera-Gonzalez R, Sellers W, Loda M et al. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res 2002; 62: 89-98.
19. Wang X, Mori I, Tang W, Nakamura M, Nakamura Y, Sato M et al. p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer 2002; 9: 216-219.
20. Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M et al. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 2007; 67: 501-510.
21. Li N, Singh S, Cherukuri P, Li H, Yuan Z, Ellisen LW et al. Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells 2008; 26: 1253-1264.
22. Bergholz J, Xiao ZX. Role of p63 in development, tumorigenesis and cancer progression. Cancer Microenviron 2012; 5: 311-322.
23. Yalcin-Ozuysal O, Fiche M, Guitierrez M, Wagner KU, Raffoul W, Brisken C. Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates. Cell Death Differ 2010; 17: 1600-1612.
24. van Bokhoven H, McKeon F. Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. Trends Mol Med 2002; 8: 133-139.
25. Britt K, Ashworth A, Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007; 14: 907-933.
26. Tiede B, Kang Y. From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res 2011; 21: 245-257.
27. Teuliere J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP et al. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 2005; 132: 267-277.
28. Thomas E, Zeps N, Cregan M, Hartmann P, Martin T. 14-3-3sigma (sigma) regulates proliferation and differentiation of multipotent p63-positive cells isolated from human breastmilk. Cell Cycle 2011; 10: 278-284.
29. Buono KD, Robinson GW, Martin C, Shi S, Stanley P, Tanigaki K et al. The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy. Dev Biol 2006; 293: 565-580.
30. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML et al. Generation of a functional mammary gland from a single stem cell. Nature 2006; 439: 84-88.
31. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993-997.
32. Stingl J, Raouf A, Emerman JT, Eaves CJ. Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia 2005; 10: 49-59.
33. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011; 479: 189-193.
34. Visvader JE, Smith GH. Murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb Perspect Biol 2011; 3: a004879.
35. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006; 8: 551-561.
36. Stein T, Salomonis N, Gusterson BA. Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia 2007; 12: 25-35.
37. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999; 13: 2604-2616.
38. Haricharan S, Li Y. STAT signaling in mammary gland differentiation, cell survival and tumorigenesis. Mol Cell Endocrinol 2013; 382: 560-569.
39. Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta 2009; 1787: 414-420.
40. Jerry DJ, Dickinson ES, Roberts AL, Said TK. Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene. J Dairy Sci 2002; 85: 1103-1110.
41. Jerry DJ, Kuperwasser C, Downing SR, Pinkas J, He C, Dickinson E et al. Delayed involution of the mammary epithelium in BALB/c-p53null mice. Oncogene 1998; 17: 2305-2312.
42. Matthews JR, Clarke AR. p53 mediates a default programme of mammary gland involution in the absence of STAT3. Oncogene 2005; 24: 3083-3090.
43. Bednorz NL, Brill B, Klein A, Gabel K, Groner B. Tracking the activation of Stat5 through the expression of an inducible reporter gene in a transgenic mouse line. Endocrinology 2011; 152: 1935-1947.
44. Britsch S. The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol 2007; 190: 1-65.
45. Long W, Wagner KU, Lloyd KC, Binart N, Shillingford JM, Hennighausen L et al. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 2003; 130: 5257-5268.
46. Suliman Y, Opitz OG, Avadhani A, Burns TC, El-Deiry W, Wong DT et al. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice. Cancer Res 2001; 61: 6467-6473.
47. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 2006; 8: R7.
48. Wagner KU, Smith GH. Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia 2005; 10: 25-36.
49. Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 2002; 129: 1377-1386.
50. Booth BW, Boulanger CA, Smith GH. Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation. J Cell Physiol 2007; 212: 729-736.
51. Matulka LA, Triplett AA, Wagner KU. Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. Dev Biol 2007; 303: 29-44.
52. Boulanger CA, Wagner KU, Smith GH. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene 2005; 24: 552-560.
53. Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci USA 2000; 97: 3444-3449.
54. Booth BW, Boulanger CA, Anderson LH, Smith GH. The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neutransformed mammary tumor cells. Oncogene 2011; 30: 679-689.
55. Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 2004; 23: 6980-6985.
56. Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C et al. Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell 2010; 17: 65-76.
57. Landis MD, Seachrist DD, Abdul-Karim FW, Keri RA. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Oncogene 2006; 25: 3325-3334.
58. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K et al. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2011; 22: 399-405.
59. Reed W, Sandstad B, Holm R, Nesland JM. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int J Surg Pathol 2003; 11: 65-74.
60. Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. J Clin Invest 2007; 117: 1370-1380.
61. Zhang Y, Yan W, Jung YS, Chen X. Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition. J Biol Chem 2012; 287: 17746-17753.
62. Ramsey MR, He L, Forster N, Ory B, Ellisen LW. Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. Cancer Res 2011; 71: 4373-4379.
63. Wu G, Osada M, Guo Z, Fomenkov A, Begum S, Zhao M et al. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res 2005; 65: 758-766.
64. Borrelli S, Candi E, Alotto D, Castagnoli C, Melino G, Vigano MA et al. p63 regulates the caspase-8-FLIP apoptotic pathway in epidermis. Cell Death Differ 2009; 16: 253-263.
65. Mills AA, Qi Y, Bradley A. Conditional inactivation of p63 by Cre-mediated excision. Genesis 2002; 32: 138-141.
66. Holembowski L, Schulz R, Talos F, Scheel A, Wolff S, Dobbelstein M et al. While p73 is essential, p63 is completely dispensable for the development of the central nervous system. Cell Cycle 2011; 10: 680-689.
67. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 1997; 25: 4323-4330.
68. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988; 54: 105-115.